At a glance
ClinicalIndex Comparison RecordN/ACompleted· 119 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
In Brief
An observational study for Glaucoma. Completed, enrolled 119 participants across 4 sites.
Detailed Summary
To determine the area under the Receiver Operator Characteristic Curve (AUC) for the Ganglion Cell Analysis (GCA) average thickness.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
CollaboratorsDataMed Devices Inc.
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
First PostedJan 2011
Primary CompletionMar 2011
TodayJul 2026
First PostedJan 7, 2011
Enrollment StartNov 1, 2010
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.5 years ago